Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

USANA Health Sciences, Inc. USNA

Consumer Defensive  —  Packaged Foods
14.50 0.24 1.68% as of 25 Sep
Market cap
$263.5M
P/E
0.0×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue 1,006.08 1,047.27 1,189.25 1,060.90 1,134.64 1,186.46 998.60 921.01 854.50 925.26
Revenue Growth 9.54% 4.09% 13.56% (10.79%) 6.95% 4.57% (15.83%) (7.77%) (7.22%) 8.28%
Cost of Revenue 180.19 179.40 200.71 187.50 209.11 217.90 193.89 176.69 161.21 200.85
Gross Profit 825.89 867.86 988.54 873.40 925.53 968.57 804.71 744.32 693.29 724.41
SG&A Expenses 687.27 735.36 800.19 727.21 749.04 798.37 697.10 651.25 626.97 680.01
Operating Income 138.62 132.50 188.35 146.19 176.49 170.19 107.61 93.07 66.32 37.43
Non-operating Income/Expense (0.07) 2.14 3.16 4.31 1.46 0.45 1.01 9.38 10.03 4.10
Non-operating Interest Expenses 0.44 0.05 0.04 0.07 0.51 0.06 0.19 0.26 0.28 0.84
EBT 138.55 134.64 191.51 150.50 177.95 170.64 108.62 102.45 76.35 41.53
Income Tax Provision 38.51 72.11 65.29 49.97 53.28 54.14 39.27 38.67 34.29 30.05
Income after Tax 100.04 62.54 126.22 100.53 124.66 116.51 69.35 63.79 42.06 11.48
Dividends (Preferred) — 0.00 0.00 — 0.00 0.00 0.00 0.00 0.00 —
Non-Controlling Interest — — — — — — — — 0.03 0.72
Net Income Common 100.04 62.54 126.22 100.53 124.66 116.51 69.35 63.79 42.03 10.76
EPS (Basic) 3.99 2.53 5.12 4.41 5.86 5.73 3.59 3.30 2.19 0.58
EPS (Diluted) 3.99 2.53 5.12 4.41 5.86 5.73 3.59 3.30 2.19 0.58
Shares (Basic, Weighted) 24.19 24.35 24.11 22.64 21.16 20.15 19.25 19.25 19.10 18.54
Shares (Diluted, Weighted) 25.05 24.71 24.64 22.82 21.26 20.34 19.31 19.35 19.16 18.57
Gross Margin 82.09% 82.87% 83.12% 82.33% 81.57% 81.63% 80.58% 80.82% 81.13% 78.29%
EBIT Margin 13.78% 12.65% 15.84% 13.78% 15.55% 14.34% 10.78% 10.11% 7.76% 4.05%
EBT margin 13.77% 12.86% 16.10% 14.19% 15.68% 14.38% 10.88% 11.12% 8.94% 4.49%
Net Profit Margin 9.94% 5.97% 10.61% 9.48% 10.99% 9.82% 6.94% 6.93% 4.92% 1.16%
Free Cash Flow Margin 10.36% 10.56% 11.86% 10.39% 12.81% 9.14% 9.36% 6.10% 5.97% 1.34%
EBITDA 152.10 148.61 205.20 169.20 199.00 192.38 129.02 113.47 88.55 77.13
EBIT 138.62 132.50 188.35 146.19 176.49 170.19 107.61 93.07 66.32 37.43
Income from Continuous Operations 100.04 62.54 126.22 100.53 124.66 116.51 69.35 63.79 42.06 11.48
Consolidated Net Income/Loss 100.04 62.54 126.22 100.53 124.66 116.51 69.35 63.79 42.06 11.48
EPS (Basic, from Continuous Ops) 4.14 2.57 5.24 4.44 5.89 5.78 3.60 3.31 2.20 0.62
EPS (Basic, Consolidated) 4.14 2.57 5.24 4.44 5.89 5.78 3.60 3.31 2.20 0.62
EPS (Diluted, from Cont. Ops) 3.99 2.53 5.12 4.41 5.86 5.73 3.59 3.30 2.20 0.62
Shares (Diluted, Average) 25.05 24.71 24.64 22.82 21.26 20.34 19.31 19.35 19.16 18.57
EPS (Diluted, Consolidated) 3.99 2.53 5.12 4.41 5.86 5.73 3.59 3.30 2.20 0.62
EBITDA Margin 15.12% 14.19% 17.25% 15.95% 17.54% 16.21% 12.92% 12.32% 10.36% 8.34%
Operating Cash Flow Margin 13.61% 11.82% 12.79% 11.95% 14.14% 10.22% 10.40% 7.67% 7.14% 2.42%

Fold the line items

In millions of $ except per-share values · columns are period end dates